Global Neurovascular Devices Market Analysis, Drivers, Restraints, Opportunities, Threats, Trends, Applications, and Growth Forecast to 2027

Neurovascular Devices Market Overview:

The Neurovascular Devices Market was valued at $24 million in 2020 & is projected to reach $34 million by 2030. It is expected to grow at a 5% CAGR between 2021 and 2030.

Request Covid - 19 Impact

Neurovascular Devices Market Report offers in-depth insights, revenue details, and other vital information regarding the global neurovascular devices market and the various trends, drivers, restraints, opportunities, and threats in the target market till 2027.

The Neurovascular Devices Market report offers insightful and detailed information regarding the various key players operating in the market, their financials, supply chain trends, technological innovations, key developments, future strategies, acquisitions & mergers, and market footprint.

The global neurovascular devices market report has been segmented based on product, application, end-use, and region.

Neurovascular devices are used to treat several neurovascular diseases such as atherosclerosis, aneurysms, arteriovenous malformations, etc. that affect the nervous system, brain, and the blood vascular system associated with it.

Neurovascular Devices Market Dynamics:

The rising prevalence of neurovascular disorders among individuals across the globe and the rising geriatric population are major factors driving the growth of the global neurovascular devices market.

In addition, increasing demand for minimally invasive surgical procedures is another factor further fueling the growth of the global market.

Moreover, ongoing product developments and increasing commercialization activities are expected to further drive the growth of the global market to a significant extent in the global market during the forecast period.

Stringent regulations and the high cost of devices are major factors hampering the growth of the global neurovascular devices market.

However, rising investments in the expansion and development of advanced healthcare infrastructure, especially in developing countries are expected to create lucrative opportunities for major players in the global market over the forecast period.

Neurovascular Devices Market Segment Analysis:

On the basis of application, the global market is segmented into ischemic strokes, cerebral aneurysms, arteriovenous malformation and fistulas, and others.

The others segment includes cerebral artery stenosis, venous sinus thrombosis, and intracranial vascular disease.

The ischemic strokes segment accounts for the highest revenue share and is expected to maintain its dominance in the global market during the next 10 years.

This dominance can be attributed to the increasing incidence of strokes among individuals across the globe, owing to unhealthy lifestyles and increasing cases of obesity.

Neurovascular Devices Market Regional Analysis:

The North American market accounts for the highest revenue share in the global neurovascular devices market and is expected to continue its dominance in the global market over the forecast period.

Rising prevalence of ischemic stroke, high healthcare spending, and advance healthcare infrastructure are major factors driving the growth of the North American neurovascular devices market currently.

The Europe neurovascular devices market is expected to witness significant revenue growth and is projected to register a CAGR of X.X% over the forecast period.

The Asia Pacific neurovascular devices market is expected to register the highest growth in terms of revenue in the global market.

The increasing aging population and rising prevalence of neurovascular diseases in countries in the region are key factors fueling the growth of the Asia Pacific neurovascular devices market.

Neurovascular Devices Market Segmentation:

Segmentation on the basis of product:

• Cerebral embolization and aneurysm coiling devices
• Cerebral angioplasty and stenting systems
• Neurothrombectomy devices
• Support devices

Segmentation on the basis of application:

• Ischemic Strokes
• Cerebral Aneurysms
• Arteriovenous Malformation and Fistulas
• Others (cerebral artery stenosis, venous sinus thrombosis, and intracranial vascular disease)

Segmentation on the basis of end-use:

• Hospitals
• Ambulatory surgical units
• Clinics

Segmentation on the basis of region:

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa